Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease ( AMBER ): results in the pre‐specified subgroup with heart failure

Heart failure drug treatment

(2019) Patrick Rossignol et al.   LANCET

Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial

(2019) Rajiv Agarwal et al.   LANCET

Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists

(2018) Marco Trevisan et al.   EUROPEAN JOURNAL OF HEART FAILURE

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults

(2018) Paul K. Whelton et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Patiromer to Enable Spironolactone Use in the Treatment of Patients with Resistant Hypertension and Chronic Kidney Disease: Rationale and Design of the AMBER Study

(2018) Rajiv Agarwal et al.   AMERICAN JOURNAL OF NEPHROLOGY

Cardiorenal Syndrome Revisited

(2018) Faiez Zannad et al.   CIRCULATION

2018 ESC/ESH Guidelines for the management of arterial hypertension

(2018) Bryan Williams et al.   EUROPEAN HEART JOURNAL

Determinants and clinical outcome of uptitration of ACE-inhibitors and beta-blockers in patients with heart failure: a prospective European study

(2017) W. Ouwerkerk et al.   EUROPEAN HEART JOURNAL

Physicians' guideline adherence is associated with better prognosis in outpatients with heart failure with reduced ejection fraction: the QUALIFY international registry

(2017) Michel Komajda et al.   EUROPEAN JOURNAL OF HEART FAILURE

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure

(2017) Clyde W. Yancy et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Resistant Hypertension and the Pivotal Role for Mineralocorticoid Receptor Antagonists: A Clinical Update 2016

(2016) Murray Epstein et al.   AMERICAN JOURNAL OF MEDICINE

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN JOURNAL OF HEART FAILURE

Resistant Hypertension

(2016) Raymond R. Townsend et al.   HYPERTENSION

Resistant hypertension: what the cardiologist needs to know

(2015) Stefano F. Rimoldi et al.   EUROPEAN HEART JOURNAL

The double challenge of resistant hypertension and chronic kidney disease

(2015) Patrick Rossignol et al.   LANCET

Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial

(2015) Bryan Williams et al.   LANCET

The Prevalence and Prognosis of Resistant Hypertension in Patients with Heart Failure

(2014) Chun-Na Jin et al.   PLoS One

Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry

(2013) Aldo P. Maggioni et al.   EUROPEAN JOURNAL OF HEART FAILURE

Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice

(2012) F. Zannad et al.   EUROPEAN HEART JOURNAL

Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial

(2011) B. Pitt et al.   EUROPEAN HEART JOURNAL